Effect of dexmedetomidine as adjuvant in supraclavicular block for upper limb orthopedic surgeries

Authors

  • Dixitkumar B. Modh Department of Anaesthesiology, GMERS Medical College and Hospital, Dharpur-Patan, Gujarat, India
  • Manthan Parmar Department of Anaesthesiology, GMERS Medical College and Hospital, Dharpur-Patan, Gujarat, India
  • Shilpin Solanki Department of Anaesthesiology, GMERS Medical College and Hospital, Dharpur-Patan, Gujarat, India

DOI:

https://doi.org/10.18203/2349-2902.isj20171589

Keywords:

Bupivacaine, Dexmedetomidine, Lignocaine, Supraclavicular block

Abstract

Background: Dexmedetomidine has anxiolytic, sedative, hypnosis, analgesic, antisialogogue and sympatholytic properties which render it suitable as an adjuvant. Hence this study was aimed to prove its efficacy as an adjuvant to lignocaine and bupivacaine for supraclavicular block in patients undergoing orthopedic upper limb surgeries. Other objectives of the study were to evaluate and compare the onset and duration of sensory and motor block as well as total analgesia, to compare effect on hemodynamic and respiratory parameters and to study any adverse effect associated with dexmedetomidine as adjuvant.

Methods: Sixty patients of ASA physical status class I & II of elective upper limb forearm orthopedic surgeries were selected in our study. Patients in group NS (n=30) received 10 ml lignocaine 2% + 20 ml bupivacaine 0.5% + 1 ml normal saline for supraclavicular block and group D (n=30) received 10 ml lignocaine 2% + 20 ml bupivacaine 0.5% + 1 µg/kg of Dexmedetomidine for the same block. The onset and duration of sensory and motor block, total duration of analgesia, need of rescue analgesic postoperatively, postoperative VAS score was assessed and compared between the two groups.

Results: Demographic data and surgical characteristics are comparable in both the groups. The onset of sensory and motor block was significantly lower (p <0.05) in group D than in group NS. The duration of sensory and motor block was significantly higher (p <0.01) in group D when compared to group NS. The duration of analgesic requirement postoperatively was significantly higher (p <0.01) in group D than group NS. No significant change in observations was made for hemodynamic parameters in both the groups.

Conclusions: Dexmedetomidine can be considered as an adjuvant to lignocaine and bupivacaine mixture for excellent quality supraclavicular block without any side effects and provide good sedation in patients undergoing orthopedic upper limb surgeries.

References

Kothari KC. Regional anaesthesia techniques for orthopaedic surgery. MJAFI. 2008;64:108-10.

Pande R, Pande M, Bhadani U, Pandey CK, Bhattacharya A. Supraclavicular block as sole anesthetic techniques. Anaesthesia. 2000;55(8):798-802.

Brown DL. Supraclavicular block anatomic analysis. Anesthesia Analgesia. 1993;66(5):415-31.

Lanz E, Theiss D, Jankovic D. Extent of blockade following various techniques of brachial plexus block. Anesth Analg. 1983;62(1):55-8.

Sahu D K, Sahu A. Lateral approach for supraclavicular block. IJA. 2010;54(3):215-8.

Murphy DB, McCartney CJ, Chan VW. Novel analgesic adjuncts for brachial plexus block: a systematic review. Anesth Analg. 2000;90(5):1122-8.

Kirksey MA, Haskins SC, Cheng J, Liu SS. Local anesthetic peripheral nerve block adjuvants for prolongation of analgesia. PLoS ONE. 2015;10(9):e0137312.

Khan ZP, Ferguson CN, Jones RM. α2 and imidazoline receptor agonists, their pharmacology & therapeutic role. Anaesthesia. 1999;54(2):146-65.

Grewal A. Dexmedetomidine: New avenues. J Anaesthesiol Clin Pharmacol. 2011;27(3):297-302.

Soni CM, Parikh H. Comparison of the motor and sensory block by Ropivacaine & Bupivacaine in combination with lignocaine in supraclavicular block Open Access. Natl J Med Res. 2013;3(4):353-7.

Mustufa A, Hassan KA, Rahman SA. Comparative study of lignocaine, Bupivacaine alone and in combination in supraclavicular block. Indian J Clin Anaesthesia. 2016;3(2):238-42.

Raizada, Chandralekha, Jain PC, Kumar A. Compounding and increase in concentration of local anaesthetic agents incraease the success rate of Brachial plexus block .IJA 2002:46(3)-193-196.

Ozgur ozmen, Hacı Ahmet ALICI, Mine ÇELiK, Aysenur DOSTBİL, Mehmet CESUR. The effect of addition of lignocaine to Bupivacaine on anaesthesia. Turk J Med Science. 2013;43:542-7.

Shariat AN, Horan PM, Gratenstein K, McCally C, Frulla AP. Equipments for peripheral nerve blocks. Anesthesia Key. Available at http://aneskey.com/equipment-for-peripheral-nerve-blocks. Accessed on 10 January 2017.

Jain A, Singh S. An improvised indigenous techniques for nerve stimulation assisted peripheral nerve blocks. Saudi J A. 2012;6:315-7.

Urmey Wf. Using the nerve stimulator for peripheral plexus nerve blocks. Minerva Anesthesiol. 2006, 467-71.

Khan ZP, Ferguson CN, Jones RM. alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role. Anaesthesia. 1999;54:146–65.

Correa-Sales C, Rabin BC, Maze M. A Hypnotic Response to Dexmedetomidine, an [alpha] 2 Agonist, Is Mediated in the Locus Coeruleus in Rats. Anesthesiol. 1992;76(6):948-52.

Nacif-Coelho C, Correa-Sales C, Chang LL, Maze M. Perturbation of Ion Channel Conductance Alters the Hypnotic Response to the [alpha] 2-Adrenergic Agonist Dexmedetomidine in the Locus Coeruleus of the Rat. Anesthesiol. 1994;81(6):1527-34.

Ralph Getler, Clieghton H Brown, Mitchel H, Silvius N. Dexmedetomidine; a novel sedative analgesic agent. Baylor university medical centre proceedings. 2001;14 (1).

Yoshitomi T, Kohjitani A, Maeda S, Higuchi H, Shimada M, Miyawaki T. Dexmedetomidine enhances local anaesthetic action of lidocaine via an alpha-2A adrenoceptor. Anesth Analg., 2008;107:96–101.

Agrawal P, Bhatt S, Upadhyay. Dexmedetomidine – a novel drug, as an adjuvant tolignocaine and bupivacaine for prolonged post –operative analgesia in supraclavicular brachial plexus block. World J Pharmacy Pharma Sci. 2015;4(11):823-34.

Sandhya A, Ritu A, Praveen G. Dexmedetomidine prolongs the effect of Bupivacaine in supraclavicular block. J Anaesthesiol Clin Pharmacol. 2014;30(1):36-40.

Biswas S, Das RK, Mukherjee G, Ghose T. Dexmedetomidine on adjuvant to levobupivacaine in supraclavicular block. Ethiopian J Health Sci. 2014;24(3):203–8.

Rachana G, Alka S, Ila P. Use of Dexmedetomidine along with Bupivacaine for brachial plexus block. NJMR. 2012;2(1):67-9.

Das A, Majumdar S, Halder S, Chattopadhyay S, Pal S, Kundu R, et al. Effect of dexmedetomidine as adjuvant in ropivacaine-induced supraclavicular brachial plexus block: A prospective, double-blinded and randomized controlled study. Saudi J Anaesth. 2014;8(1):72-7.

Downloads

Published

2017-04-22

Issue

Section

Original Research Articles